Abnormalities of vascular function in resistant hypertension

Blood Pressure

Volumn 21, Issue 2, 2012, Pages 104-109

  De La Sierra, Alejandro ^a   Larrousse, María ^b   Oliveras, Anna ^c   Armario, Pedro ^d   Hernández Del Rey, Raquel ^d   Poch, Esteban ^e   Roca Cusachs, Alejandro ^f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE MATARÓ   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d Hospital General de l'Hospitalet   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

ambulatory blood pressure monitoring; arterial compliance; endothelial dysfunction; inflammatory biomarkers; resistant hypertension

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPEREMIA; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RESISTANT HYPERTENSION; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VASODILATATION; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD PRESSURE MONITORING, AMBULATORY; BLOOD VESSELS; COMPLIANCE; FEMALE; FOREARM; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASODILATION;

EID: 84859060293     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2011.622983     Document Type: Article

References (33)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419.
2. De la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57: 898-902.
3. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14:1263-1269. (Pubitemid 33151484)
4. Hern án dez del Rey R, Armario P, Martí n-Baranera M, Castellanos P. Clustering of cardiovascular risk factors and prevalence of metabolic syndrome in subjects with resistant hypertension. Med Cl í n (Barc). 2006;127:241-245 [Article in Spanish].
5. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. True resistant hypertension: Isit possible to be recognized in the office? Am J Hypertens. 2005;18:1534-1540.
6. Oliveras A, Armario P, Hernandez-del Rey R, Arroyo JA, Poch E, Larrousse M, et al. Urinary albumin excretion isassociated with true resistant hypertension. J Hum Hypertens. 2010;24:27-33.
7. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, et al. Cardiovascular outcome intreated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422-1428. (Pubitemid 41566669)
8. Salles GF, Cardoso CRL, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168:2340-2346.
9. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study. Hypertension. 1998;31:712-718.
10. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007;115:1285-1295. (Pubitemid 46594773)
11. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104: 191-196. (Pubitemid 32655837)
12. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001; 104:1336-1342. (Pubitemid 32880144)
13. De Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690-695. (Pubitemid 36222595)
14. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241. (Pubitemid 34163575)
15. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension. J Hypertens. 2007;25:1105-1187.
16. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848. (Pubitemid 36677141)
17. Bragulat E, de la Sierra A, Antonio MT, Coca A. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension. 2001;37:444-448. (Pubitemid 32199009)
18. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001;87:121-125. (Pubitemid 32013961)
19. Oliveras A, de la Sierra A, Martinez-Estrada OM, Larrousse M, Vazquez S, Soler MJ, et al. Putative endothelial progenitor cells are associated with flow-mediated dilation in refractory hypertensives. Blood Press. 2008;17:298-305.
20. De la Sierra A, Larrousse M. Endothelial dysfunction isassociated with increased levels of biomarkers in essential hypertension. J Hum Hypertens. 2010;24:373-379.
21. Larrousse M, Bragulat E, Sagarra M, Sierra C, Coca A, de la Sierra A. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Am J Hypertens. 2006;19: 87-93. (Pubitemid 43217040)
22. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension. 1995;26: 503-508.
23. Finkelstein SM, Cohn JN. First- and third-order models for determining arterial compliance. J Hypertens. 1992;10 Suppl: S11-S14.
24. Taddei S, Salvetti A. Endothelial dysfunction in essential hypertension: Clinical implications. J Hypertens. 2002;20: 1671-1674.
25. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42:1067-1074. (Pubitemid 37549057)
26. Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am. 2008;37:685-711.
27. Nishizaka MK, Zaman MA, Green SA, Renfroe KY, Calhoun DA. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation. 2004;109:2857-2861. (Pubitemid 38780298)
28. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med. 1999;340:115-126.
29. Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension. 2007;50:723-728. (Pubitemid 47442737)
30. Duprez DA, Kaiser DR, Whitwam W, Finkelstein S, Belalcazar A, Patterson R, et al. Determinants of radial artery pulse wave analysis in asymptomatic individuals. Am J Hypertens. 2004; 17:647-653. (Pubitemid 39091544)
31. Grey E, Bratteli C, Glasser SP, Alinder C, Finkelstein SM, Lindgren BR, et al. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens. 2003;16:265-269. (Pubitemid 36384752)
32. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-1225.
33. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: Clinical implications. Drugs. 2002;62:265-284. (Pubitemid 34169434)